Dianthus Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $284 | $396 | $193 | $1,163 |
Gross Profit | 284 | 396 | 193 | 1,163 |
EBITDA | -69,282 | -36,738 | -34,828 | -33,044 |
EBIT | -69,541 | -36,765 | -34,927 | -33,177 |
Net Income | 97,905 | -36,765 | -31,629 | -29,511 |
Net Change In Cash | 284 | 396 | 193 | 1,163 |
Free Cash Flow | -47,121 | -30,560 | -23,938 | -27,654 |
Cash | 51,087 | 55,984 | 13,237 | 10,116 |
Basic Shares | 37,794 | 37,794 | 35,822 | 35,791 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,036 | $6,235 | $2,826 | $6,417 |
Gross Profit | 2,036 | 6,235 | 2,826 | 6,417 |
EBITDA | -177,933 | -101,452 | -47,819 | -29,558 |
EBIT | -101,864 | -48,174 | -29,705 | |
Net Income | -162,337 | -84,969 | -43,555 | -28,476 |
Net Change In Cash | 2,036 | 6,235 | 2,826 | 6,417 |
Free Cash Flow | -129,273 | -78,285 | -36,971 | -29,209 |
Cash | 51,087 | 22,792 | 132,325 | 15,365 |
Basic Shares | 37,794 | 33,314 | 5,153 | 3,747 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.43 |
2025-09-30 | -$0.97 |
2025-06-30 | -$0.88 |
2025-03-31 | -$0.82 |
